Clinical trial
HELIOS China Registry: A Prospective, Single-arm, Multicenter Study to Evaluate the HELIOS Biodegradable Polymer Sirolimus-eluting Stent in a 'Real-World' Patient Population
NCT03916432 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HELIOS China Registry: A Prospective, Single-arm, Multicenter Study to Evaluate the HELIOS Biodegradable Polymer Sirolimus-eluting Stent in a 'Real-World' Patient Population
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2018
- Completion date
- December 1, 2025
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.